If you look at the Agenda for the Dec 15 AGM it looks pretty boring. Just the usual routine election of officers and a financial statement.

What is not there is any mention of approval of a Regional licencing deal, although Don has stated there will be one before the end of the year, no mention of a progress update on the Betonmace phase three trial. The update after the AGM is what will be interesting. If Don has a regional deal ready to announce, why isn't it on the Agenda for a vote?

This leads me to another question, what happens to these regional deals if Resverlogix is sold or at least Apabetalone(RVX 208) is sold? Could the sale of Apabetalone be the reason Don has not announced the second Licencing agreement? How is Don going to address the Loc coming due Aug 2017? There are many other questions raised by BearDownAR on Nov 25th.

There seems to be a lot of unanswered questions and I hope Don has some answers come the update folowing the meeting. If Don doesn't have answers then maybe that is why he is waiting until the election of officers is completed before updating us.